[
    {
        "program_id": "PROGRAM_1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_1",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1",
        "treatment_type": "No treatment",
        "is_primary_treatment": "Yes",
        "treatment_start_date": "2021-11",
        "treatment_end_date": "2022-09",
        "treatment_setting": "Adjuvant",
        "treatment_intent": "Curative",
        "days_per_cycle": 3,
        "number_of_cycles": 3,
        "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
        "response_to_treatment": "Complete response"
    },
    {
        "program_id": "PROGRAM_1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_2",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2",
        "treatment_type": "Chemotherapy",
        "is_primary_treatment": "No",
        "treatment_start_date": "2021-01",
        "treatment_end_date": "2022-07",
        "treatment_setting": "Not applicable",
        "treatment_intent": "Curative",
        "days_per_cycle": 2,
        "number_of_cycles": 4,
        "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
        "response_to_treatment": "Stable disease"
    },
    {
        "program_id": "PROGRAM_1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_3",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3",
        "treatment_type": "Endoscopic therapy",
        "is_primary_treatment": "Yes",
        "treatment_start_date": "2021-03",
        "treatment_end_date": "2022-03",
        "treatment_setting": "Neoadjuvant",
        "treatment_intent": "Curative",
        "days_per_cycle": 4,
        "number_of_cycles": 4,
        "response_to_treatment_criteria_method": "AML Response Criteria",
        "response_to_treatment": "Complete response"
    },
    {
        "program_id": "PROGRAM_1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_4",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4",
        "treatment_type": "Radiation therapy",
        "is_primary_treatment": "No",
        "treatment_start_date": "2021-09",
        "treatment_end_date": "2022-04",
        "treatment_setting": "Adjuvant",
        "treatment_intent": "Palliative",
        "days_per_cycle": 3,
        "number_of_cycles": 5,
        "response_to_treatment_criteria_method": "iRECIST",
        "response_to_treatment": "Stable disease"
    },
    {
        "program_id": "PROGRAM_1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_5",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_5",
        "treatment_type": "Surgery",
        "is_primary_treatment": "No",
        "treatment_start_date": "2021-02",
        "treatment_end_date": "2022-11",
        "treatment_setting": "Adjuvant",
        "treatment_intent": "Palliative",
        "days_per_cycle": 3,
        "number_of_cycles": 4,
        "response_to_treatment_criteria_method": "Physician Assessed Response Criteria",
        "response_to_treatment": "Stable disease"
    },
    {
        "program_id": "PROGRAM_2",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_6",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_6",
        "treatment_type": "Hormonal therapy",
        "is_primary_treatment": "No",
        "treatment_start_date": "2021-10",
        "treatment_end_date": "2022-07",
        "treatment_setting": "Adjuvant",
        "treatment_intent": "Curative",
        "days_per_cycle": 2,
        "number_of_cycles": 4,
        "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria",
        "response_to_treatment": "NED"
    },
    {
        "program_id": "PROGRAM_2",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_7",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_7",
        "treatment_type": "Photodynamic therapy",
        "is_primary_treatment": "Yes",
        "treatment_start_date": "2021-07",
        "treatment_end_date": "2022-07",
        "treatment_setting": "Adjuvant",
        "treatment_intent": "Palliative",
        "days_per_cycle": 3,
        "number_of_cycles": 5,
        "response_to_treatment_criteria_method": "iRECIST",
        "response_to_treatment": "Disease progression"
    },
    {
        "program_id": "PROGRAM_2",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_8",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_8",
        "treatment_type": "Ablation",
        "is_primary_treatment": "Yes",
        "treatment_start_date": "2021-09",
        "treatment_end_date": "2022-01",
        "treatment_setting": "Neoadjuvant",
        "treatment_intent": "Palliative",
        "days_per_cycle": 1,
        "number_of_cycles": 5,
        "response_to_treatment_criteria_method": "iRECIST",
        "response_to_treatment": "Complete response"
    },
    {
        "program_id": "PROGRAM_2",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_9",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_9",
        "treatment_type": "No treatment",
        "is_primary_treatment": "No",
        "treatment_start_date": "2021-06",
        "treatment_end_date": "2022-02",
        "treatment_setting": "Adjuvant",
        "treatment_intent": "Palliative",
        "days_per_cycle": 6,
        "number_of_cycles": 4,
        "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)",
        "response_to_treatment": "Complete response"
    },
    {
        "program_id": "PROGRAM_2",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_10",
        "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_10",
        "treatment_type": "Immunotherapy",
        "is_primary_treatment": "No",
        "treatment_start_date": "2021-06",
        "treatment_end_date": "2022-07",
        "treatment_setting": "Advanced/Metastatic",
        "treatment_intent": "Curative",
        "days_per_cycle": 2,
        "number_of_cycles": 4,
        "response_to_treatment_criteria_method": "AML Response Criteria",
        "response_to_treatment": "Stable disease"
    }
]
